Antiangiogenic Cancer Therapy: Monitoring with Molecular US and a Clinically Translatable Contrast Agent (BR55)

Relationship Between Retention of a Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)-Targeted Ultrasonographic Contrast Agent and the Level of VEGFR2 Expression in an In Vivo Breast Cancer Model

(2017) Debbie J. Lee et al.   JOURNAL OF ULTRASOUND IN MEDICINE

Targeted Contrast-Enhanced Ultrasound Imaging of Tumor Angiogenesis with Contrast Microbubbles Conjugated to Integrin-Binding Knottin Peptides

(2010) J. K. Willmann et al.   JOURNAL OF NUCLEAR MEDICINE

Ultrasound molecular imaging of atherosclerosis

(2009) B. A. Kaufmann   CARDIOVASCULAR RESEARCH

Preparation of targeted microbubbles: ultrasound contrast agents for molecular imaging

(2009) Alexander L. Klibanov   MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING

Follow-up of hepatic and peritoneal metastases of gastrointestinal tumors (GIST) under Imatinib therapy requires different criteria of radiological evaluation (size is not everything!!!)

(2008) Mylène Mabille et al.   EUROPEAN JOURNAL OF RADIOLOGY

Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects

(2008) M. Palmowski et al.   MOLECULAR CANCER THERAPEUTICS

Molecular imaging in drug development

(2008) Jürgen K. Willmann et al.   NATURE REVIEWS DRUG DISCOVERY

Dual-targeted Contrast Agent for US Assessment of Tumor Angiogenesis in Vivo

(2008) Jürgen K. Willmann et al.   RADIOLOGY

Targeted Microbubbles for Imaging Tumor Angiogenesis: Assessment of Whole-Body Biodistribution with Dynamic Micro-PET in Mice

(2008) Jürgen K. Willmann et al.   RADIOLOGY

US Imaging of Tumor Angiogenesis with Microbubbles Targeted to Vascular Endothelial Growth Factor Receptor Type 2 in Mice

(2008) Jürgen K. Willmann et al.   RADIOLOGY